0001144204-17-009675.txt : 20170216 0001144204-17-009675.hdr.sgml : 20170216 20170216192433 ACCESSION NUMBER: 0001144204-17-009675 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170210 FILED AS OF DATE: 20170216 DATE AS OF CHANGE: 20170216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DERMA SCIENCES, INC. CENTRAL INDEX KEY: 0000892160 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 232328753 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6095144744 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DERMA SCIENCES INC DATE OF NAME CHANGE: 19940513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eigner Frederic CENTRAL INDEX KEY: 0001322419 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13070 FILM NUMBER: 17619443 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 v459891_form4.xml FORM 4 X0306 4 2017-02-10 0 0000892160 DERMA SCIENCES, INC. DSCI 0001322419 Eigner Frederic DERMA SCIENCES, INC. 214 CARNEGIE CENTER, SUITE 300 PRINCETON NJ 08540 0 1 0 0 Executive VP - Operations Common Stock 2017-02-10 4 M 0 9375 6.40 A 60199 D Common Stock 2017-02-10 4 F 0 8571 7.00 D 51628 D Common Stock 2017-02-14 4 A 0 7100 0 A 58728 D Common Stock 2017-02-14 4 F 0 3550 7.00 D 55178 D Stock Option (right to buy) 6.40 2017-02-10 4 M 0 9375 0 D 2007-03-01 2017-02-22 Common Stock 9375 0 D Stock Option (right to buy) 3.30 2017-02-14 4 A 0 21200 0 D 2017-02-14 2027-02-14 Common Stock 21200 21200 D Shares delivered in connection with the cashless exercise of 9,375 options, previously granted pursuant to the issuer's stock option plan, at an exercise price of $6.40, as reported herein. The shares of common stock reported herein represent restricted stock units issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on March 2, 2016, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2016, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2016 were met, resulting in the vesting of 7,100 restricted stock units. Shares withheld in connection with the vesting of 7,100 restricted stock units, previously granted pursuant to the issuer's equity incentive plan, at a price of $7.00, as reported herein. A total of 75,000 of the options were granted pursuant to the issuer's stock option plan on March 1, 2007. Options for 25% of the shares vested immediately and options for the remaining shares vested at the rate of 25% per year starting on February 22, 2008. The revised total of 9,375 options reflects the issuer's 1-for-8 reverse split effective January 1, 2010. The options were originally granted in consideration of the reporting person's services to the issuer and without payment of cash. The options reported herein were issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on March 2, 2016, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2016, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2016 were met, resulting in the vesting of 21,200 options. /s/ Frederic Eigner 2017-02-16